We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Creo Medical Group Plc | LSE:CREO | London | Ordinary Share | GB00BZ1BLL44 | ORD GBP0.001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.50 | -1.40% | 35.25 | 35.00 | 35.50 | 35.75 | 35.25 | 35.75 | 197,799 | 10:14:20 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Surgical,med Instr,apparatus | 27.17M | -26.94M | -0.0746 | -4.73 | 127.34M |
Date | Subject | Author | Discuss |
---|---|---|---|
02/1/2024 07:23 | Thanks Mike. 24 Oct 2022 Kamaptive Licence and Royalty Agreement with CMR Surgical | wan | |
02/1/2024 07:11 | Really?Creo Medical Group PLC Kamaptive Licence and Royalty Agreement with CMR | mikeh30 | |
02/1/2024 06:51 | Why have you put a link to CMR on a CREO chat ? | pacsltd | |
01/1/2024 21:58 | https://cmrsurgical. | mikeh30 | |
01/1/2024 21:34 | https://x.com/rckhll | bloomberg2 | |
01/1/2024 20:51 | Straight out of the blocks 8am !! One to watch I believe | stevehuges | |
01/1/2024 08:08 | https://x.com/rckhll | bloomberg2 | |
30/12/2023 16:21 | https://x.com/creome | bloomberg2 | |
30/12/2023 16:19 | https://creomedical. | bloomberg2 | |
30/12/2023 13:24 | https://x.com/rckhll | bloomberg2 | |
30/12/2023 13:19 | https://x.com/rckhll | bloomberg2 | |
30/12/2023 12:04 | Nice find ! | bloomberg2 | |
30/12/2023 10:51 | This is the rns from June regarding NICESpeedboat (TM) Inject selected by NICE for assessmentCreo Medical Group plc (AIM: CREO), the medical device company focused on the emerging field of surgical endoscopy, announces that the National Institute for Health and Care Excellence ("NICE") has selected Speedboat Inject to be scoped and routed for guidance in respect of the endoscopic submucosal dissection ("ESD") of lower gastrointestinal ("GI") lesions.This selection follows a committee review of headline data and initiates a multi-step process whereby Speedboat's lower GI ESD clinical and economic evidence, along with other data, is evaluated by NICE and, if appropriate, may result in a specific NICE output such as Medical Technologies Guidance.NICE selected Speedboat Inject for scoping and routing because it "anticipate[s] the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources". | master investor | |
29/12/2023 20:28 | Speed boat !! Amazing tool for Achalasia patients!! | bloomberg2 | |
29/12/2023 19:46 | https://x.com/rckhll | bloomberg2 | |
29/12/2023 12:17 | Will check | bloomberg2 | |
29/12/2023 12:07 | Yes that enforcement is due anytime | master investor | |
29/12/2023 12:06 | The break out on the chart has attracted a lot of people who have been waiting on the sidelines. | master investor | |
29/12/2023 11:19 | That'll do for starters !!!! | bloomberg2 | |
29/12/2023 11:13 | Trading update due in January | master investor | |
29/12/2023 11:05 | Could see a spectacular rerate now 40p has been breached.At £1 the market cap will be £361M, peanuts to the likes of Intuity for such ground breaking tech which is getting rolled out globally. | parob | |
29/12/2023 10:53 | I'm I right more news expected in January? | bloomberg2 | |
29/12/2023 10:50 | ,apart from COVID any other reason for the drop over the last years? | arab3 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions